Procter & Gamble Company
Exchange: NYSESector: Consumer DefensiveIndustry: Household & Personal Products
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide.
Did you know?
Price sits at 19% of its 52-week range.
Current Price
$142.85
+0.37%GoodMoat Value
$122.70
14.1% overvaluedProfile
Valuation (TTM)
Market Cap$333.80B
P/E20.29
EV$362.28B
P/B6.42
Shares Out2.34B
P/Sales3.92
Revenue$85.26B
EV/EBITDA14.75
Procter & Gamble Company (PG) Stock Analysis
GoodMoat Analysis
Procter & Gamble is a high-quality, moat-protected consumer staples giant, but its current valuation appears elevated relative to its intrinsic value. The company exhibits strong brand power and operational excellence, yet its slow growth and premium price present a classic value investing dilemma. Further investigation is warranted, but primarily to wait for a more attractive entry point.
Read full analysis
Procter & Gamble (P&G) is a global leader in branded consumer packaged goods, owning a vast portfolio of essential household and personal care products like Tide, Pampers, and Gillette. Applying the GoodMoat framework, P&G demonstrates a durable competitive moat, scoring highly on criteria like Brand & Culture (global household names), Scale Privilege (massive manufacturing and distribution reach), and Pricing Power (proven ability to pass on costs). Its consistent profitability, with an ROE of 31.6% and an operating margin of 24.3%, supports a high-quality business profile. However, its growth is mature, with revenue growth of just 1.5% YoY. The Decision Framework analysis is mixed. The company passes the Moat & Quality Gate with ease, but stumbles at the Valuation & Risk Gate. The GoodMoat Target price of $122.70 suggests the current price of $143.92 offers a negative margin of safety, placing it in the 'Unfavourable' valuation band. While the P/E of 20.4x is not extreme, it is high for a low-growth company, and the FCF Yield of 4.2% is modest. For a value investor, P&G represents a quintessential 'great company at a fair price' scenario. The business is robust and defensive, but the valuation does not provide the necessary discount to intrinsic value required for a favourable risk/reward setup. Further investigation should focus on the sustainability of its margins and potential catalysts for a better price.
Market Cap$333.80B
Current Price$142.85
P/E Ratio20.29
Forward P/E—
PEG Ratio-3.28
EPS$6.51
Book Value$22.26
P/B Ratio6.42
PG Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use 2.8% FCF growth (CAGR)
Cash vs Debt
Net Debt: 25.0B
Revenue
67.7B
FY19
71.0B
FY20
76.1B
FY21
80.2B
FY22
82.0B
FY23
84.0B
FY24
84.3B
FY25
Net Income
3.9B
FY19
13.0B
FY20
14.3B
FY21
14.7B
FY22
14.7B
FY23
14.9B
FY24
16.0B
FY25
PG 52-Week Range
$137.08
$167.20
50-Day MA: $151.19200-Day MA: $149.80
Did you know?
Trading 14% above its estimated fair value of $122.70.
Procter & Gamble Company (PG) Financial Summary
Procter & Gamble Company (PG) is a Consumer Defensive company in the Household & Personal Products industry, listed on NYSE. The stock currently trades at $142.85 with a market capitalization of $333.80B.
Key valuation metrics include a P/E ratio of 20.29, price-to-book ratio of 6.42, and EPS of $6.51. The company reports a profit margin of 19.3% and return on equity of 31.6%.
PG Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $333.80B |
| P/E Ratio | 20.29 |
| EPS | $6.51 |
| P/B Ratio | 6.42 |
| P/S Ratio | 3.92 |
| EV/EBITDA | 14.75 |
| Dividend Yield | 2.96% |
| Profit Margin | 19.3% |
| Return on Equity | 31.6% |
| Debt/Equity | 0.66 |
PG Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $67.68B | $3.90B |
| FY20 | $70.95B | $13.03B |
| FY21 | $76.12B | $14.31B |
| FY22 | $80.19B | $14.74B |
| FY23 | $82.01B | $14.65B |
| FY24 | $84.04B | $14.88B |
| FY25 | $84.28B | $15.97B |
Procter & Gamble Company (PG) Valuation
Based on GoodMoat's DCF model, Procter & Gamble Company has a fair value estimate of $122.70. At the current price of $142.85, the stock appears 16.4% overvalued relative to our intrinsic value estimate.
PG Quality Indicators
Procter & Gamble Company maintains a profit margin of 19.3% and an operating margin of 24.3%. Return on equity stands at 31.6%. The current ratio is 0.70. Debt-to-equity ratio is 0.66.
About Procter & Gamble Company
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide.
PG Free Cash Flow
Procter & Gamble Company generated $14.04B in trailing twelve-month free cash flow, representing an FCF yield of 4.21%. This moderate FCF yield indicates reasonable cash generation.
PG Shares Outstanding
Procter & Gamble Company has 2.34 billion shares outstanding at a share price of $142.85, giving it a market capitalization of $333.80B.
PG Recent Insider Trades
Recent insider transactions at Procter & Gamble Company include:
| Insider | Type | Shares | Value |
|---|---|---|---|
| Francisco Ma. Fatima (CEO - Baby, Fem & Family Care) | SELL | 5,249 | $867607.21 |
| Whaley Susan Street (Chief Legal Officer & Secy) | SELL | 1,809 | $288454.28 |
| Aguilar Moses Victor Javier (Chf Rsch, Dev & Innov Officer) | SELL | 15,169 | $2.46M |